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Response to Letter by Hadjiev and Mineva
Response:
Professor Hadjiev and Dr Mineva have raised the following
question: Which patients having asymptomatic carotid artery steno-
sis (ACAS) might benefit from screening? In our study,1 we
reported accurate prevalence estimates of moderate and severe
ACAS in the general population. We fully agree that these data
might be helpful for further studies of cost-effectiveness of screen-
ing the general population for ACAS. Many factors, however, affect
the cost-effectiveness of screening in an asymptomatic population.
In their commentary, Hadjiev and Mineva call for additional
studies to help to clarify geographic and race–ethnic differences in
the distribution patterns of vascular risk factors related to ACAS.2
We suggest that careful decision modeling, followed by other
targeted studies only as needed to clarify key areas of uncertainty,
should play a key role in decisions about screening for ACAS in the
general population or certain high-risk populations.3 By bringing
together information about test performance, treatment efficacy,
population-level distributions of disease rates, and competing mor-
bidity and mortality, decision modeling can help provide answers to
the question of who should be screened for ACAS.
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